Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent GBM von Geens, W., Du Four, S., Van Laere, S., Schwarze, J.K., Awada, G., Tijtgat, J., Bruneau, M., Everaert, H., Neyns, B., Duerinck, J.

Volltext

371P Low-dose bevacizumab for the treatment of focal post-radiation necrosis of the brain von Tijtgat, J., Schwarze, J.K., Awada, G., Neyns, B.

Volltext

A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus int... von Schwarze, J.K., Awada, G., Van Riet, I., Neyns, B.

Volltext

1131P C-reactive protein as biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting von Lauwyck, J., Beckwée, A., Santens, A., Schwarze, J.K., Awada, G., Vandersleyen, V., Aspeslagh, S., Neyns, B.

Volltext

962MO A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells (myDC) in combination with talimogene laherparepvec (T... von Schwarze, J.K., Tijtgat, J., Awada, G., Cras, L., Dufait, I., Forsyth, R., Van Riet, I., Tuyaerts, S., Neyns, B.

Volltext

20P Interim safety and efficacy results of a phase II clinical trial on trametinib and low-dose dabrafenib in patients with advanced BRAFV600 wild-type melanoma von Awada, G., Schwarze, J.K., Reijmen, E., Goyvaerts, C., Fasolino, G., Aspeslagh, S., Neyns, B.

Volltext

839P A retrospective study on the long-term survival and incidence of metachronous malignancies in advanced melanoma patients treated with immune checkpoint blockade (ICB) von Verschaeve, F., Vandelaer, N., Vander Mijnsbrugge, A-S., Tijtgat, J., Schwarze, J.K., Awada, G., Kessels, J., Aspeslagh, S., Cools, W., Rogiers, A., Neyns, B.

Volltext

809P Outcomes of patients with resected stage III/IV acral or mucosal melanoma treated with adjuvant anti-PD-1 therapy von Jacques, S.K., McKeown, J., Grover, P., Park, B., Zaremba, A., Dimitriou, F., Harunal Rashid, M.F., Namikawa, K., Mooradian, M., Placzke, J., Allayous, C., Mehmi, I., DePalo, D., Wicky, A., Schwarze, J.K., Nakamura, Y., Benannoune, N., Menzies, A.M., Lo, S.N., Carlino, M.S.

Volltext

342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial von Neyns, B., Schwarze, J.K., Bertels, C., Geens, W., Tijtgat, J., Awada, G., Vaeyens, F., Cras, L., Vanbinst, A-M., Everaert, H., Michotte, A., Bruneau, M., Forsyth, R., Tuyaerts, S., Duerinck, J.

Volltext

1047P Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM) von Bhave, P., Ahmed, T., Shoushtari, A.N., Zaremba, A., Versluis, J.M., Mangana, J., Weichenthal, M., Si, L., Lesimple, T., Robert, C., Trojaniello, C., Wicky, A., Heywood, R., Tran, L., Batty, K., Stansfeld, A., Lebbe, C., Schwarze, J.K., Mooradian, M., Carlino, M.

Volltext

Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab von Awada, G., Özdemir, I., Schwarze, J.K., Daeninck, E., Gondry, O., Jansen, Y., Seremet, T., Keyaerts, M., Everaert, H., Neyns, B.

Volltext

65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients... von Schwarze, J.K., Bertels, C., Awada, G., Tijtgat, J., Tuyaerts, S., Cras, L., Vaeyens, F., Vanbinst, A-M., Everaert, H., Michotte, A., Caljon, B., Olsen, C., Janssen, T., Van Dooren, S., Forsyth, R., Duerinck, J., Neyns, B.

Volltext

Real-life data of hepatitis C treatment with direct acting antiviral therapy in persons injecting drugs or on opioid substitution therapy von M., Pfaeffle, S., Duenkelmann, C, Boesecke, J.K., Rockstroh, C., Schwarze-Zander

Volltext

Rabies post-exposure prophylaxis in Germany − What are the challenges? von Meyerhoff, P., Manekeller, S., Saleh, N., Boesecke, C., Schlabe, S., Wasmuth, J.C., van Bremen, K., Eis-Hübinger, A.M., von Fischer-Treuenfeld, J., Menting, T., Rockstroh, J.K., Schwarze-Zander, C.

Volltext

Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks? von Menting, T., Krause, K., Benz-Tettey, F., Boehringer, R., Laufer, D., Gruber, B., Crump, M., Schieferdecker, R., Reuhl, S., Kaeferstein, A., Engelhart, S., Streeck, H., Marx, B., Aldabbagh, S., Eis-Hübinger, A., Rockstroh, J.K., Schwarze-Zander, C.

Volltext

P0700 : Immunological rather than virological response to haart is associated with improved anti-HCV NK cell activity in HIV patients von Glässner, A, Krämer, B, Wolter, F, Kokordelis, P, Goeser, F, Kaczmarek, D, Boesecke, C, Schwarze-Zander, C, Strassburg, C.P, Spengler, U, Rockstroh, J.K, Nattermann, J

Volltext

359 HLA FOOTPRINTS IN HIV/HCV CO-INFECTED PATIENTS von Dold, L, Althausen, E, Schwarze-Zander, C, Boesecke, C, Wasmuth, J.-C, Strassburg, C.P, Rockstroh, J.K, Spengler, U

Volltext

1087 PEGINTERFERON-ALFA MONO-THERAPY SHOWS FAVOURABLE OUTCOME WHEN INITIATED EARLY AFTER DIAGNOSIS OF ACUTE HCV IN HIV-INFECTED PATIENTS von Boesecke, C, van Assen, S, Stellbrink, H.-J, Baumgarten, A, Ingiliz, P, Schwarze-Zander, C, Wasmuth, J.-C, Hoepelman, A.I.M, Rockstroh, J.K, Arends, J.E

Volltext

How successful is influenza vaccination in HIV infected patients? Results from an influenza A(H1N1)pdm09 vaccine study von Schwarze-Zander, C, Steffens, B, Emmelkamp, J, Kümmerle, T, Boesecke, C, Wasmuth, J.C, Strassburg, C.P, Fätkenheuer, G, Rockstroh, J.K, Eis-Hübinger, A.M

Volltext

Transplantation of “thymoheart” allografts in miniature swine von Menard, M.T., Mawulawde, K., Yamada, K., Schwarze, M.L., Lee, R.S., Slisz, J.K., Allison, K.S., Sachs, D.H., Madsen, J.C.

Volltext